Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01633411 · ClinicalTrials.gov registry record
Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium
A clinical trial, sponsored by Pentax Medical.
- Completed
- Registry status
- 39
- Enrollment target
NCT01633411: Completed study, sponsored by Pentax Medical.
NCT01633411 is a clinical trial that has completed, run by Pentax Medical. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01633411 has completed, sponsored by Pentax Medical.
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
This is a feasibility study without a primary study hypothesis or statistical comparison.
Primary Outcome
Stricture formation is defined as none, mild (non-circumferential stenosis allowing easy passage of diagnostic endoscope), moderate (circular stenosis allowing passage of diagnostic endoscope), and severe (any stenosis preventing the passage of a diagnostic scope).
Interventions
- DEVICE Focal Cryoballoon Ablation System - 6 seconds
- DEVICE Focal Cryoballoon Ablation System - 8 seconds
- DEVICE CryoBalloon Focal Ablation System - 10 seconds
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-06 |
What the finished NCT01633411 record still lists
NCT01633411 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Focal Cryoballoon Ablation System - 6 seconds is the first listed.
NCT01633411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01633411 about?
NCT01633411 is a clinical study titled "Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium". This is a feasibility study without a primary study hypothesis or statistical comparison.
What is the current status of trial NCT01633411?
This trial is currently completed. The enrollment target is 39 participants. The study started on 2011-12. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01633411?
The interventions under investigation include: Focal Cryoballoon Ablation System - 6 seconds (DEVICE), Focal Cryoballoon Ablation System - 8 seconds (DEVICE), CryoBalloon Focal Ablation System - 10 seconds (DEVICE).
Who is sponsoring clinical trial NCT01633411?
This trial is sponsored by Pentax Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia